… the mechanisms of resistance to dopamine agonist therapy, and … prolactinomas
resistant to dopamine agonist therapy. … invasive macroadenomas than dopamine agonist–responsive …

… Obviously, such invasive prolactinomas cannot be cured by surgery, regardless of the surgical
technique employed or experience of the neurosurgeon, and it will not always be possible …

… prolactinomas, the following keywords were searched in PubMed database: prolactinoma
AND (invasive … entities of “invasive”, “aggressive” and “malignant” prolactinomas and pituitary …

… prolactinomas, bromocriptine has been regarded as a first-line agent for invasive prolactinoma
[… Nevertheless, cabergoline was not chosen as the initial dopamine agonist in this study, …

… One recognized but uncommon complication of dopamine agonist (DA) treatment for
invasive … We report five cases of massive invasive prolactinomas treated with DA (three with …

… CSF rhinorrhoea arises when an invasive prolactinoma creates a CSF fistula through the
dura and osseous skull base, followed by DA-induced tumour shrinkage and unmasking of the …

… Noteworthy, some studies found that the expression of D2S mRNA was significantly different
for invasive and non-invasive tumors (62), thus researchers should pay more attention to …

… patients treated with dopamine agonists for prolactinoma, but … Hardy’s tumor score (less
invasive tumor), and the presence … are defined as “aggressive” if they are radiologically invasive…

… dopamine agonists… dopamine agonists, with healthy subjects being the most sensitive and
women in the early puerperium the least [77]. Side effects associated with dopamine agonists …

… recommend dopamine agonists (DAs) as the mainstay treatment for prolactinomas. In most
… This is particularly true for aggressive prolactinomas in which surgery and radiotherapy may …